Model Number 7300TFX25 |
Device Problems
Gradient Increase (1270); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Cardiogenic Shock (2262); Thrombosis/Thrombus (4440)
|
Event Date 11/09/2023 |
Event Type
Injury
|
Event Description
|
It was reported that a patient with an 25mm 7300tfx, underwent a valve-in-valve procedure after an implant duration of 11 days due to iatrogenic mitral stenosis with possible thrombus on the valve.The tmvr was performed with a 26mm 9750tfx transcatheter valve.Per medical records, patient initially underwent an mvr due to severe native mr with a 25mm mitral ease valve.The patient later underwent valve-in-valve procedure with a 26mm s3 valve.Intraoperatively, the previously noted laa was no longer demonstrated.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
|
|
Manufacturer Narrative
|
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.
|
|
Event Description
|
It was reported that a patient with an 25mm 7300tfx, underwent a valve-in-valve procedure after an implant duration of 5 days due to iatrogenic mitral stenosis.The tmvr was performed with a 26mm 9750tfx transcatheter valve.Per medical records, patient initially underwent mvr ((b)(6) 2023) and later presented with cardiogenic shock, dic with ecmo and impella devices placed, and developed profound gradient over the next two days which improved on heparin drip.On pod#2 there was no obvious thrombosis or mechanical impingement of the leaflets.On pod#5, mitral gradient was 30mmhg with left atrial appendage (laa) thrombus.The patient later underwent valve-in-valve procedure with a 26mm s3 valve.Intraoperatively, the previously noted laa was no longer demonstrated.
|
|
Manufacturer Narrative
|
The subject device was not returned for evaluation as it was remains implanted within the patient and no pictures of the device were provided for evaluation.Medical records were, however, provided for review, confirming the reported iatrogenic mitral stenosis.A dhr review was performed and no relevant non-conformances were identified.The complaint was was confirmed through medical records.There is no evidence to suggest an edwards/supplier manufacturing defect.Based on the limited information available, the complaint is confirmed and the most likely cause is due to patient factors, including a blood clot that contributed with the early mitral stenosis.An edwards defect has not been confirmed.
|
|
Search Alerts/Recalls
|